Bharat Biotech airlifts vaccine to 11 cities

Bharat Biotech received order for 55 lakh doses from the Centre. It donated 16.5 lakh doses to the govt. Each Covaxin vial contains 20 doses

Bharat Biotech received order for 55 lakh doses from the Centre. It donated 16.5 lakh doses to the govt. Each Covaxin vial contains 20 doses

This post was originally published on The Asian Age | Home.


Print Share Comment Cite Upload Translate
APA
Age Correspondent | radiofree.asia (2021-06-20T04:05:32+00:00) » Bharat Biotech airlifts vaccine to 11 cities. Retrieved from https://radiofree.asia/2021/01/13/bharat-biotech-airlifts-vaccine-to-11-cities/.
MLA
" » Bharat Biotech airlifts vaccine to 11 cities." Age Correspondent | radiofree.asia - Wednesday January 13, 2021, https://radiofree.asia/2021/01/13/bharat-biotech-airlifts-vaccine-to-11-cities/
HARVARD
Age Correspondent | radiofree.asia Wednesday January 13, 2021 » Bharat Biotech airlifts vaccine to 11 cities., viewed 2021-06-20T04:05:32+00:00,<https://radiofree.asia/2021/01/13/bharat-biotech-airlifts-vaccine-to-11-cities/>
VANCOUVER
Age Correspondent | radiofree.asia - » Bharat Biotech airlifts vaccine to 11 cities. [Internet]. [Accessed 2021-06-20T04:05:32+00:00]. Available from: https://radiofree.asia/2021/01/13/bharat-biotech-airlifts-vaccine-to-11-cities/
CHICAGO
" » Bharat Biotech airlifts vaccine to 11 cities." Age Correspondent | radiofree.asia - Accessed 2021-06-20T04:05:32+00:00. https://radiofree.asia/2021/01/13/bharat-biotech-airlifts-vaccine-to-11-cities/
IEEE
" » Bharat Biotech airlifts vaccine to 11 cities." Age Correspondent | radiofree.asia [Online]. Available: https://radiofree.asia/2021/01/13/bharat-biotech-airlifts-vaccine-to-11-cities/. [Accessed: 2021-06-20T04:05:32+00:00]
rf:citation
» Bharat Biotech airlifts vaccine to 11 cities | Age Correspondent | radiofree.asia | https://radiofree.asia/2021/01/13/bharat-biotech-airlifts-vaccine-to-11-cities/ | 2021-06-20T04:05:32+00:00
https://github.com/addpipe/simple-recorderjs-demo



A Free News Initiative

Investigative Journalism for People, Not Profits.

Discussion